Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.61 |
| ▸ | GAA | P10253 | 6/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6790901 | 0.86 | KDM4E (0.56) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6783336 | 0.82 | KDM4E (0.56) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6783637 | 0.81 | KDM4E (0.70) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6783544 | 0.81 | KDM4E (0.74) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL29642712 | 0.81 | KDM4E (0.74) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6781147 | 0.77 | KDM4E (0.94) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6791224 | 0.74 | KMT2A (0.55) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6780670 | 0.73 | KMT2A (0.53) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| SCHEMBL6780160 | 0.73 | KDM4E (0.58) | ALDH1A1KDM4EGAAKMT2AHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL1111035 | 0.71 | KDM4E (0.51) | ALDH1A1KDM4EGAAKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6693112-B2 | FOR INHIBITING DRUG TRANSPORT FROM TARGET CELLS OR TISSUES IN AN ANIMAL UNDERGOING CHEMOTHERAPY; FOR PREVENTING DRUG RESISTANCE | THE PENNSYLVANIA STATE UNIVERSITY | 2004-02-17 | — | — | US | claimed |
| US-20030105122-A1 | Compounds for enhancing chemotherapy | THE PENN STATE RESEARCH FOUNDATION. | 2003-06-05 | — | — | US | claimed |
| EP-1272479-A2 | NOVEL COMPOUNDS FOR ENHANCING CHEMOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2003-01-08 | — | — | EP | claimed |
| US-20020013322-A1 | Novel compounds for enhancing chemotherapy | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-01-31 | — | — | US | claimed |
| WO-2001074790-A2 | NOVEL COMPOUNDS FOR ENHANCING CHEMOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2001-10-11 | — | — | WO | claimed |
| US-6815442-B2 | A PHENOXY-ALKYL-QUINOXALINONE DERIVATIVES FOR INHIBITING DRUG TRANSPORT PROTEINS THAT EFFLUX THERAPEUTIC AGENTS FROM CELLS; SYNERGISTIC | THE PENN STATE RESEARCH FOUNDATION | 2004-11-09 | — | — | US | disclosed |
| US-6693112-B2 | FOR INHIBITING DRUG TRANSPORT FROM TARGET CELLS OR TISSUES IN AN ANIMAL UNDERGOING CHEMOTHERAPY; FOR PREVENTING DRUG RESISTANCE | THE PENNSYLVANIA STATE UNIVERSITY | 2004-02-17 | — | — | US | disclosed |
| US-20030203910-A1 | Novel compounds for enhancing chemotherapy | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-30 | — | — | US | disclosed |
| US-20030105122-A1 | Compounds for enhancing chemotherapy | THE PENN STATE RESEARCH FOUNDATION. | 2003-06-05 | — | — | US | disclosed |
| US-6537993-B2 | Compounds for enhancing chemotherapy | PENN STATE RESEARCH FOUNDATION | 2003-03-25 | — | — | US | disclosed |
| EP-1272479-A2 | NOVEL COMPOUNDS FOR ENHANCING CHEMOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020013322-A1 | Novel compounds for enhancing chemotherapy | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-01-31 | — | — | US | disclosed |
| WO-2001074790-A2 | NOVEL COMPOUNDS FOR ENHANCING CHEMOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2001-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203910-A1 | Novel compounds for enhancing chemotherapy | ABCB1, ABCB11, ABCC1 | ALDH1A1 2236/4885KDM4E 4040/4885GAA 799/4885 |
| US-20020013322-A1 | Novel compounds for enhancing chemotherapy | ABCB1, ABCB11, ABCC1 | ALDH1A1 2236/4885KDM4E 4040/4885GAA 799/4885 |
| US-20030105122-A1 | Compounds for enhancing chemotherapy | NQO2, MCL1, ABCB1 | ALDH1A1 555/4885KDM4E 748/4885GAA 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.